TASMAN PHARMA FDA Approval ANDA 215186

ANDA 215186

TASMAN PHARMA

FDA Drug Application

Application #215186

Application Sponsors

ANDA 215186TASMAN PHARMA

Marketing Status

Prescription001

Application Products

001OINTMENT;TOPICALEQ 0.05% BASE0BETAMETHASONE DIPROPIONATEBETAMETHASONE DIPROPIONATE

FDA Submissions

UNKNOWN; ORIG1AP2022-02-18STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

TASMAN PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215186
            [companyName] => TASMAN PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"BETAMETHASONE DIPROPIONATE","activeIngredients":"BETAMETHASONE DIPROPIONATE","strength":"EQ 0.05% BASE","dosageForm":"OINTMENT;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/18\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-02-18
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.